A rare case of infectious mononucleosis complicated by guillain-barre syndrome

Margaret Kennedy1, Mariya Apostolova

  • 1Division of Hematology/Oncology, The Western Pennsylvania Hospital, Pittsburgh, PA.

Insights

Guillain-Barre syndrome is a rare neurologic complication of infectious mononucleosis. This case report details a patient who fully recovered with supportive treatment after developing Guillain-Barre syndrome post-Epstein-Barr virus infection.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Immunology

Background:

  • Infectious mononucleosis, a syndrome caused by Epstein-Barr virus, typically presents with fever, lymphadenopathy, and pharyngitis.
  • Neurologic complications are infrequent and often manifest late in the disease course.
  • Guillain-Barre syndrome is a rare but serious neurological complication associated with infectious mononucleosis.

Observation:

  • A 29-year-old male with no prior significant medical history presented with symptoms suggestive of infectious mononucleosis.
  • The patient was subsequently diagnosed with Guillain-Barre syndrome following Epstein-Barr virus infection.
  • This presentation occurred relatively early in the disease course.

Findings:

  • The case highlights a rare instance of Guillain-Barre syndrome developing shortly after an Epstein-Barr virus infection.
  • The patient received supportive care for the neurological complication.
  • Complete recovery was achieved through prompt and appropriate management.

Implications:

  • This case underscores the importance of considering Guillain-Barre syndrome in patients with infectious mononucleosis, even with atypical timing.
  • Early recognition and supportive treatment are crucial for favorable outcomes in Guillain-Barre syndrome.
  • Further research may elucidate the precise mechanisms linking Epstein-Barr virus and Guillain-Barre syndrome.

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...